Literature DB >> 24718709

Experimental and computational studies of physicochemical properties influence NSAID-cyclodextrin complexation.

Linda A Felton1, Carmen Popescu, Cody Wiley, Emilio Xavier Esposito, Philippe Lefevre, Anton J Hopfinger.   

Abstract

The objective of this research was to investigate physicochemical properties of an active pharmaceutical ingredient (API) that influence cyclodextrin complexation through experimental and computational studies. Native β-cyclodextrin (B-CD) and two hydroxypropyl derivatives were first evaluated by conventional phase solubility experiments for their ability to complex four poorly water-soluble nonsteroidal anti-inflammatory drugs (NSAIDs). Differential scanning calorimetry was used to confirm complexation. Secondly, molecular modeling was used to estimate Log P and aqueous solubility (S o) of the NSAIDs. Molecular dynamics simulations (MDS) were used to investigate the thermodynamics and geometry of drug-CD cavity docking. NSAID solubility increased linearly with increasing CD concentration for the two CD derivatives (displaying an AL profile), whereas increases in drug solubility were low and plateaued in the B-CD solutions (type B profile). The calculated Log P and S o of the NSAIDs were in good concordance with experimental values reported in the literature. Side chain substitutions on the B-CD moiety did not significantly influence complexation. Explicitly, complexation and the associated solubility increase were mainly dependent on the chemical structure of the NSAID. MDS indicated that each NSAID-CD complex had a distinct geometry. Moreover, complexing energy had a large, stabilizing, and fairly constant hydrophobic component for a given CD across the NSAIDs, while electrostatic and solvation interaction complex energies were quite variable but smaller in magnitude.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24718709      PMCID: PMC4113631          DOI: 10.1208/s12249-014-0110-2

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  39 in total

1.  Deviation from linearity of drug solubility in ethanol/water mixtures.

Authors:  Stephen G Machatha; Pilar Bustamante; Samuel H Yalkowsky
Journal:  Int J Pharm       Date:  2004-09-28       Impact factor: 5.875

2.  Structure-based in silico model profiles the binding constant of poorly soluble drugs with β-cyclodextrin.

Authors:  Haiyan Li; Jin Sun; Yongjun Wang; Xiaofan Sui; Le Sun; Jiwen Zhang; Zhonggui He
Journal:  Eur J Pharm Sci       Date:  2010-10-25       Impact factor: 4.384

3.  Development of improved empirical models for estimating the binding constant of a beta-cyclodextrin inclusion complex.

Authors:  Ravi Chari; Farooq Qureshi; John Moschera; Ralph Tarantino; Devendra Kalonia
Journal:  Pharm Res       Date:  2008-10-09       Impact factor: 4.200

4.  Co-solvent solubilization of some poorly-soluble antidiabetic drugs.

Authors:  Neelam Seedher; Mamta Kanojia
Journal:  Pharm Dev Technol       Date:  2009       Impact factor: 3.133

Review 5.  Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs.

Authors:  Arik Dahan; Jonathan M Miller; Gordon L Amidon
Journal:  AAPS J       Date:  2009-10-30       Impact factor: 4.009

6.  In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.

Authors:  Wen Kou; Cuifang Cai; Shuying Xu; Huan Wang; Jing Liu; Dan Yang; Tianhong Zhang
Journal:  Int J Pharm       Date:  2011-03-01       Impact factor: 5.875

7.  Affinity of drugs and small biologically active molecules to carbon nanotubes: a pharmacodynamics and nanotoxicity factor?

Authors:  John Liu; Liu Yang; Anton J Hopfinger
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

8.  Sulfobutyl ether-alkyl ether mixed cyclodextrin derivatives with enhanced inclusion ability.

Authors:  Serena Tongiani; Tetsuya Ozeki; Valentino J Stella
Journal:  J Pharm Sci       Date:  2009-12       Impact factor: 3.534

9.  Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.

Authors:  Y-H Phillip Lee; Sateesh Sathigari; Y-J Jean Lin; William R Ravis; Gurkishan Chadha; Daniel L Parsons; Vijay K Rangari; Nydeia Wright; R Jayachandra Babu
Journal:  Drug Dev Ind Pharm       Date:  2009-09       Impact factor: 3.225

10.  Investigation into the mechanism by which cyclodextrins influence transdermal drug delivery.

Authors:  Clifford L Kear; Jing Yang; Donald A Godwin; Linda A Felton
Journal:  Drug Dev Ind Pharm       Date:  2008-07       Impact factor: 3.225

View more
  3 in total

1.  Cholecalciferol complexation with hydroxypropyl-β-cyclodextrin (HPBCD) and its molecular dynamics simulation.

Authors:  Fang Wang; Wenbo Yu; Carmen Popescu; Ahmed Ashour Ibrahim; Dongyue Yu; Ryan Pearson; Alexander D MacKerell; Stephen W Hoag
Journal:  Pharm Dev Technol       Date:  2022-04-25       Impact factor: 3.915

Review 2.  Inclusion Complexes of Non-Steroidal Anti-Inflammatory Drugs with Cyclodextrins: A Systematic Review.

Authors:  Gustavo Marinho Miranda; Vitória Ohana Ramos E Santos; Jonatas Reis Bessa; Yanna C F Teles; Setondji Cocou Modeste Alexandre Yahouédéhou; Marilda Souza Goncalves; Jaime Ribeiro-Filho
Journal:  Biomolecules       Date:  2021-02-27

3.  Non-ionic thiolated cyclodextrins - the next generation.

Authors:  Ali Moghadam; Muhammad Ijaz; Mulazim Hussain Asim; Arshad Mahmood; Max Jelkmann; Barbara Matuszczak; Andreas Bernkop-Schnürch
Journal:  Int J Nanomedicine       Date:  2018-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.